1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.
Enrollment closed, study ongoing
Nationwide Children's HospitalPhase 1/2 NCT04211675 Registry history of NCT04211675 on ClinicalTrials.gov (opens the registry)
Updated
| Early Phase 1 | 3 | |
| Phase 1 | 2 | |
| Phase 1/2 | 7 | |
| Phase 2 | 10 | |
| Phase 2/3 | 1 | |
| Phase 3 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT07291102 | Comparison of Neurocognitive Outcome in Two Standard Regimen for Treatment of Low-risk… | Medulloblastoma | Not Yet Recruiting | 2025-12-18 |
| Phase 2/3 | ||||
| NCT05267821 | Targeted Reversal of Inflammation in Pediatric Sepsis-induced MODS | Pediatric Sepsis-induced Multiple Organ Dysfunction Syndrome (MODS) | Recruiting | 2026-03-13 |
| Phase 2 | ||||
| NCT06838676 | ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High… | Diffuse Intrinsic Pontine Gliomas (DIPG) | Recruiting | 2026-09-21 |
| NCT05096481 | PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and… | High Grade Glioma | Recruiting | 2026-08-24 |
| NCT05843253 | Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG… | High Grade Glioma | Recruiting | 2026-05-29 |
| NCT05233397 | ACTEMRA® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma | Adamantinomatous Craniopharyngioma | Recruiting | 2026-04-23 |
| NCT05286788 | MEKTOVI® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma | Adamantinous Craniopharyngioma | Recruiting | 2026-04-08 |
| NCT05135975 | A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in… | Neuroblastoma | Recruiting | 2025-08-12 |
| NCT04467671 | Two-Year Study of the Safety and Efficacy of the Second-Generation Tissue Engineered… | HLH - Hypoplastic Left Heart Syndrome | Recruiting | 2025-06-27 |
| NCT07644312 | Study of Relatlimab and Nivolumab (Opdualag) in Replication Repair Deficient HGG and DIPG | High Grade Glioma | Not Yet Recruiting | 2026-09-09 |
| NCT07206849 | Study of Tovorafenib in High-Grade Glioma and Diffuse Intrinsic Pontine Glioma (DIPG) | High Grade Glioma (HGG) of the Brain With BRAF Aberration | Not Yet Recruiting | 2026-07-31 |
| NCT02378428 | MIBG Therapy for Patients With MIBG Avid Tumors | MIBG Avid Tumors | Active, Not Recruiting | 2025-05-13 |
| Phase 1/2 | ||||
| NCT05278208 | Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors | High Grade Glioma | Recruiting | 2026-07-20 |
| NCT05634369 | A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK Cell… | Pediatric Sarcoma, Refractory | Recruiting | 2026-01-28 |
| NCT04722029 | Pilot Study of Haploidentical Donor Adenovirus Specific T-lymphocytes to Treat Refractory… | Adenovirus Infection | Recruiting | 2025-05-13 |
| NCT05503134 | Safety and Efficacy of Expanded, Universal Donor Natural Killer Cells for… | Acute Myeloid Leukemia | Recruiting | 2024-11-04 |
| NCT04211675 | NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab | Relapsed Neuroblastoma | Active, Not Recruiting | 2026-09-16 |
| NCT03431090 | Haploidentical Hematopoietic Cell Transplantation for Children With Hematologic… | Myelodysplasia | Active, Not Recruiting | 2026-04-03 |
| NCT07026942 | Phase I/II Clinical Trial of Universal Donor CD33 CAR Natural Killer Cells for AML | Relapsed/Refractory AML | Not Yet Recruiting | 2025-11-12 |
| Phase 1 | ||||
| NCT04254419 | Phase 1 Study of Locoregional Injections of Ex Vivo Expanded Natural Killer Cells | High Grade Glioma | Recruiting | 2025-05-13 |
| NCT03605550 | A Phase 1b Study of PTC596 in Children With Newly Diagnosed Diffuse Intrinsic Pontine… | High Grade Glioma | Active, Not Recruiting | 2026-03-27 |
| Early Phase 1 | ||||
| NCT06333899 | Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion | High Grade Glioma | Recruiting | 2026-06-29 |
| NCT04655404 | A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion | High Grade Glioma | Recruiting | 2026-03-18 |
| NCT05779930 | Safety and Feasibility of CD19 CAR T Cells Using CliniMACS Prodigy for… | Acute Lymphoblastic Leukemia, in Relapse | Not Yet Recruiting | 2025-08-15 |
| Not applicable | ||||
| NCT07798180 | Transauricular Neurostimulation for Abdominal Pain Due to DGBI | Abdominal Pain (AP) | Recruiting | 2026-09-01 |
Glioma (12) · Leukemia (6) · Acute Lymphoblastic Leukemia (ALL) (4) · Heart Disease (4) · Anxiety (3) · Glioblastoma (3) · Acute Myeloid Leukemia (AML) (2) · Sarcoma (2) · Diabetes (1) · Duchenne Muscular Dystrophy (1)